Patents by Inventor Irini Lazou Ahrén

Irini Lazou Ahrén has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for celiac disease using lactobacillus strains
    Patent number: 11166993
    Abstract: The present invention relates to at least one probiotic strain of Lactobacillus for use in a subject for the prevention and/or treatment of celiac disease autoimmunity (CDA), or for use in the prevention and/or treatment of celiac disease (CD). A preferred composition for use according to the invention is a composition comprising a combination of Lactobacillus paracasei and Lactobacillus plantarum, especially L. paracasei 8700:2 (DSM 13434) in combination with L. plantarum HEAL 9 (DSM 15312).
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: November 9, 2021
    Assignee: Probi AB
    Inventors: Daniel Agardh, Irini Lazou Ahrén, Lars Niklas Larsson
  • PROBIOTIC COMPOSITIONS AND USES THEREOF
    Publication number: 20210113633
    Abstract: The invention relates to at least one probiotic strain chosen from Lactobacillus paracasei 8700:2 (DSM 13434) and/or at least one probiotic strain of Lactobacillus piantarum, for use in the treatment and/or prevention of trabecular bone loss, in a mammal, preferably in anon-rodent mammal, more preferably in a human, most preferably in a peri-menopausal woman, post-menopausal woman or a woman six years or less after onset of menopause.
    Type: Application
    Filed: June 13, 2019
    Publication date: April 22, 2021
    Inventors: Claes Sven Anders Ohlsson, Niklas Larsson, Irini Lazou Ahrén
  • PROBIOTIC COMPOSITIONS AND USES THEREOF
    Publication number: 20190358275
    Abstract: The present invention relates to at least one probiotic strain of Lactobacillus for use in a subject for the prevention and/or treatment of celiac disease autoimmunity (CDA), or for use in the prevention and/or treatment of celiac disease (CD). A preferred composition for use according to the invention is a composition comprising a combination of Lactobacillus paracasei and Lactobacillus plantarum, especially L. paracasei 8700:2 (DSM 13434) in combination with L. plantarum HEAL 9 (DSM 15312).
    Type: Application
    Filed: January 12, 2018
    Publication date: November 28, 2019
    Inventors: Daniel Agardh, Irini Lazou Ahrén, Lars Niklas Larsson
  • Probiotic strains for use in treatment or prevention of osteoporosis
    Patent number: 10245290
    Abstract: The present invention relates to at least one probiotic strain chosen from Lactobacillus paracasei, or at least one probiotic strain chosen from Lactobacillus paracaseiin combination with at least one probiotic strain chosen from Lactobacillus plantarum, for use in the treatment or prevention of osteoporosis or for use in increasing the absorption of at Ca2+ ions, in a mammal, preferably in a human.
    Type: Grant
    Filed: April 3, 2014
    Date of Patent: April 2, 2019
    Assignee: Probi AB
    Inventors: Anna Berggren, Niklas Larsson, Gunilla Önning, Irini Lazou Ahrén, Klara Sjögren, Claes Ohlsson